This is the authors' abstract. We don't add key points for this paper.
Haemoglobinopathies, which include thalassemia and structural haemoglobin variants, are the most common inherited disease affecting an estimated 20% of the world’s population.1 Globally, ∼300,000 children are born annually with haemoglobinopathies, making it the most clinically significant monogenic disorder.2 It is estimated that thalassemia contributes to approximately 3.4% of deaths in children under 5 years.2 Thalassemia poses a significant economic cost globally, with estimated per patient care cost of $128,000 annually.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: